Skip to main content
Premium Trial:

Request an Annual Quote

Igenomix, Ferring Pharmaceuticals Collaborate to Study Infertility, Pregnancy Conditions

NEW YORK – Igenomix and Ferring Pharmaceuticals said on Thursday that they have entered into a two-year research collaboration to discover novel targets and disease mechanisms in infertility and pregnancy-related conditions, including preeclampsia.

The companies said they are aiming to develop diagnostics and therapeutics in these areas of high unmet need. Under the terms of the deal, Igenomix, based in Valencia, Spain, and Ferring, headquartered in Saint-Prex, Switzerland, will create a new research hub in Boston to help their respective scientists work together. The hub will focus on investigating molecular signatures, developing novel functional genomic systems, and creating translational tools to study embryo implantation, endometrial microbiome interactions, and decidualization biology.

Financial terms of the deal were not disclosed.

"This new research hub will connect Igenomix's unique diagnostic capabilities with Ferring's deep therapeutic expertise," Carlos Simón, head of Igenomix Foundation's scientific board and project lead for the new hub, said in a statement. "We believe this collaboration will accelerate scientific findings and improve conception rates at a time when significant progress is needed in preimplantation science to help more women and families experience healthy pregnancies."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.